NDT Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NDTP research report →
About the company
NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.
- CEO
- James Hovis
- IPO
- 2008
- HQ
- Vienna, VA, US
Price Chart
- Market Cap
- $73.51M
- P/E
- 2297.15
- P/S
- 0.00
- P/B
- 1466.01
- EV/EBITDA
- -3221.40
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -33.16%
- ROIC
- -49.47%
- Revenue
- $0 · 0.00%
- Net Income
- $-22,819 · -36.71%
- EPS
- $0.00 · 300.00%
- Op Income
- $-22,819
- FCF YoY
- 0.00%
- 52W High
- $2.10
- 52W Low
- $0.05
- 50D MA
- $0.53
- 200D MA
- $0.96
- Beta
- 0.00
- Avg Volume
- 1.59K
Get TickerSpark's AI analysis on NDTP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 29, 07 | CARASQUERO FRANCISCO KENT | other | 96,000 |
| Mar 28, 07 | CARASQUERO FRANCISCO KENT | other | 0 |
| Mar 28, 07 | CARASQUERO FRANCISCO KENT | other | 0 |
| Jun 2, 06 | XINOS JOHN ANASTASIOS | other | 0 |
Our NDTP coverage
Recent articles, reports, and earnings notes.
No research on NDTP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NDTP report →Similar companies
Peers in the same neighborhood.